РусскийEnglishУкраїнська
  • Главная
  • Полезные ссылки
  • О журнале
  • Авторам
  • Редакционная коллегия

  • Статья
    Емченко Я.А., Ищейкин К.Е., Кайдашев И.П.

    СОВРЕМЕННЫЕ ВЗГЛЯДЫ НА ИММУНОПАТОГЕНЕЗ ПСОРИАЗА


    Об авторе: Емченко Я.А., Ищейкин К.Е., Кайдашев И.П.
    Рубрика КЛИНИЧЕСКАЯ МЕДИЦИНА
    Тип статьи Научная статья.
    Аннотация Статья посвящена обзору данных литературы о роли иммунных расстройств в патогенезе псориаза. Приведены новые данные по исследованию воспаление, которое возникает в коже больных и приводит к развитию системного воспаления у больных псоріазом, роли недавно открытого IL-33 и поляризации макрофагов в патогенезе псориаза, что позволяет расширить представление о механизме развития дерматоза, выявить новые мишени терапии, определить параметры оценки тяжести и активности заболевания.
    Ключевые слова псориаз, иммунопатогенез, цитокины, IL-33, поляризация макрофагов
    Список цитируемой литературы
    • Belozorov A. Novaia subpopuliatsiya effektornykh khelpernykh T-lymfotsytov (TH22) y ee uchastye v patoheneze zabolevanyi kozhy.  Dermatolohiya ta venerolohiya. 2010; 2 (48): 7-10. [in Russian]
    • Hayrutdinov VR. Rol immunnoy sistemy kozhi v patogeneze psoriaza. Immunopatol, allergol, infektol. 2012; 2:54-62. [in Russian]
    • Hayrutdinov VR. Rol CD11c-kletok Rol CD11c pozitivnykh dendritnykh kletok v patogeneze psoriaza. Vestn dermatol i venerol 2012; 3: 58—64. [in Russian]
    • Hayrutdinov VR. Immunogistokhimicheskiy analiz kozhi bolnyih psoriazom. Tsitokiny i vospaleniye 2012; 11 (3): 27-34. [in Russian]
    • Kamylov FKh, Mufazalova NA, Kapuler OM. Tsytokinovyi dysbalans v immunopatogeneze psoriaza. Fundamentalni doslidzhennia. 2015; 1 (5):1065-1071. [in Russian]
    • Liamyna S, Malushev Y. Poliaryzatsyia makrofagov v sovremennoy kontseptsii formirovaniya immunnogo otveta. Fundamentalnye issledovaniya. 2014;  10 (5):930-935. [in Russian]
    • Monastyrskaya E, Liamyna S, Malushev Y. M1 y M2 fenotyp aktivirovannykh makrofagov i ikh rol v immunnom otvete i patologii. Patohenez.  2008; №4: 31— 39. [in Russian]
    • Yemchenko Ya, Ishcheikin K. Deiaki spilni aspekty patohenezu psoriazu ta metabolichnoho syndromu. Svit medytsyny ta biolohi.  2013; № 1:176-180. [in Ukrainian]
    • Yemchenko Ya. Riven pokaznykiv systemnoho zapalennia u khvorykh na psoriaz obtiazhenyi metabolichnym syndromom. Zhurnal dermatovenerolohii ta kosmetolohii imeni M .O.Torsueva.  2018; № 1 (38):31-35. [in Ukrainian]
    • Bertheloot D, Latz E. HMGB1, IL-1a, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol. 2017; 14(1):43-64.
    • Bovenschen HJ, Van de Kerkhof PC, Van Erp PE. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17Aproducing cells and are found in lesional skin. J invest dermatol 2011; 9: 9—16.
    • Boyman O, Conrad C, Tonel G. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol 2007; 28: 51-7.
    • Cargill M, Schrodi SJ, Chang M. et al. A largescale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80:273-90.
    • Cassol E1, Cassetta L, Rizzi C, Alfano M, Poli G. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J Immunol. 2009 May 15; 182(10):37-46.
    • Chan JR, Blumenschein W, Murphy E. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 2006; 203: 77-87.
    • Chong SZ, Wong KL, Lin G. et al. Human CD8. T cells drive Th1 responses through the differentiation of TNF/iNOS-producing dendritic cells. Eur J Immunol 2011; 41 (6): 1639-51.
    • Clark RA. Resident memory T cells in human health and disease. Sci Transl Med 2015; 7 (269):269-274.
    • Cosmi L, Liotta F, Maggi E. Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin. Int Arch Allergy Immunol 2014; 164 (3): 171-177.
    • Gratchev A, Kzhyshkowska J, Köthe K, Muller-Molinet I, Kannookadan S, Utikal J, Goerdt S. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology. 2006; 211(6-8):473-86.
    • Dominique Talabot-Ayera, Thomas McKee, Patrizia Gindre. Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Joint, bone, spine: revue du rhumatisme 2011; 79(1):32-7. 
    • Harden JL, Krueger JG, Bowcock AM. The immunogenetics of Psoriasis: A comprehensive review. J Autoimmun. 2015 Nov; 64:66-73.
    • Hsu HC, Yang P, Wang J. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008; 9: 166-75.
    • Jae Ho Han, Chang-Hee Suh, Ju-Yang Jung. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still’s Disease. Rheumatology. 2017; 5(8):121-127.
    • Jung SL, Baek JH, Lee JH. Efficacy and Safety of Radiofrequency Ablation for Benign Thyroid Nodules: A Prospective Multicenter Study.  Radiol. 2018;19(1):167-174. 
    • Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16(11):676-689.
    • Lowes MA, Russell CB, Martin DA, Towne JE, Krueger JG. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol 2013; 34: 174-181.
    • Martinez F, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008 Jan 1; №13:453-61.
    • Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014; Mar 3(6):13-18.
    • Mitsui A, Tada Y, Takahashi T, Shibata S, Kamata M. Serum IL‐33 levels are increased in patients with psoriasis. Experimental dermatology. 2015; 3(2):234-239.
    • Mitsui A, Tada Y, Takahashi T, Shibata S. Serum IL‐33 levels are increased in patients with psoriasis. Experimental dermatology. 2014; 5(2):247-253.
    • Naik HB, Cowen EW. Autoinflammatory pustular neutrophilic diseases. Dermatol. Clin.  2013; 3: 405-425.
    • Оuser LA, Wright JF, Dunussi-Joannopoulos K, Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 2008; 226: 87-102.
    • Panshyna N, Shylova L, Aleksandrov A. Klynycheskoe znachenye ynterleikyna-8 pry psoryatycheskom artryte. Vestnyk Volhohradskoho hosudarstvennoho medytsynskoho unyversyteta. 2015; 3 (55):51-53. [in Russian]
    • Sebastian Drube, Florian Kraft, Jan Dudeck. MK2/3 Are Pivotal for IL-33–Induced and Mast Cell–Dependent Leukocyte Recruitment and the Resulting Skin Inflammation. J Immunol. 2016; 2(10):35-42.
    • Teng M, Bowman E, Smyth M, Casanova J, Cooper A, Cua D. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med. 2015; 21(7):719-29.
    • Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL. et al. Psoriasis - as an autoimmune disease caused by molecular mimicry. Trends Immunol 2009; 30 (10): 494-501.
    Публикация статьи «Мир Медицины и Биологии» №3(65), 2018 год, 134-139 страницы, код УДК 616.517:612.017
    DOI 10.26724/2079-8334-2018-3-65-134-139